share_log

8-K: Current report

8-K: Current report

8-K：重大事件
美股sec公告 ·  05/13 08:04
Moomoo AI 已提取核心訊息
Cingulate Inc., a company listed on the Nasdaq Capital Market, has reported a series of compliance efforts with Nasdaq's listing rules in a recent Form 8-K filing dated May 13, 2024. The company had previously fallen out of compliance with the Nasdaq's minimum stockholders' equity requirement of $2.5 million. In response, Cingulate submitted a compliance plan on June 30, 2023, and was granted an extension until November 13, 2023, to meet the requirement, which included raising additional capital. Despite these efforts, Nasdaq notified the company of a potential delisting due to non-compliance. A hearing with the Nasdaq Hearings Panel took place on February 13, 2024, after which the company appointed three independent board members on February 12, 2024, regaining compliance with Nasdaq's board composition requirements. The Panel also granted Cingulate an exception to demonstrate continued compliance with the stockholders' equity requirement through May 13, 2024. As of the filing date, Cingulate believes it has met the stockholders' equity threshold. However, the company acknowledges that until Nasdaq confirms full compliance, the risk of delisting remains.
Cingulate Inc., a company listed on the Nasdaq Capital Market, has reported a series of compliance efforts with Nasdaq's listing rules in a recent Form 8-K filing dated May 13, 2024. The company had previously fallen out of compliance with the Nasdaq's minimum stockholders' equity requirement of $2.5 million. In response, Cingulate submitted a compliance plan on June 30, 2023, and was granted an extension until November 13, 2023, to meet the requirement, which included raising additional capital. Despite these efforts, Nasdaq notified the company of a potential delisting due to non-compliance. A hearing with the Nasdaq Hearings Panel took place on February 13, 2024, after which the company appointed three independent board members on February 12, 2024, regaining compliance with Nasdaq's board composition requirements. The Panel also granted Cingulate an exception to demonstrate continued compliance with the stockholders' equity requirement through May 13, 2024. As of the filing date, Cingulate believes it has met the stockholders' equity threshold. However, the company acknowledges that until Nasdaq confirms full compliance, the risk of delisting remains.
在納斯達克資本市場上市的公司Cingulate Inc. 在最近於2024年5月13日提交的8-K表格中報告了一系列遵守納斯達克上市規則的努力。該公司此前未遵守納斯達克250萬美元的最低股東權益要求。作爲回應，Cingulate於2023年6月30日提交了一份合規計劃，並獲准將期限延長至2023年11月13日，以滿足該要求，其中包括籌集額外資金。儘管做出了這些努力，納斯達克還是通知該公司可能因違規而退市。納斯達克聽證會小組於2024年2月13日舉行了聽證會，之後該公司於2024年2月12日任命了三名獨立董事會成員，重新遵守了納斯達克的董事會組成要求。該小組還批准了Cingulate的例外情況，以證明在2024年5月13日之前繼續遵守股東權益要求。截至申請日，Cingulate認爲其已達到股東權益門檻。但是，該公司承認，在納斯達克確認完全合規之前，退市的風險仍然存在。
在納斯達克資本市場上市的公司Cingulate Inc. 在最近於2024年5月13日提交的8-K表格中報告了一系列遵守納斯達克上市規則的努力。該公司此前未遵守納斯達克250萬美元的最低股東權益要求。作爲回應，Cingulate於2023年6月30日提交了一份合規計劃，並獲准將期限延長至2023年11月13日，以滿足該要求，其中包括籌集額外資金。儘管做出了這些努力，納斯達克還是通知該公司可能因違規而退市。納斯達克聽證會小組於2024年2月13日舉行了聽證會，之後該公司於2024年2月12日任命了三名獨立董事會成員，重新遵守了納斯達克的董事會組成要求。該小組還批准了Cingulate的例外情況，以證明在2024年5月13日之前繼續遵守股東權益要求。截至申請日，Cingulate認爲其已達到股東權益門檻。但是，該公司承認，在納斯達克確認完全合規之前，退市的風險仍然存在。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息